Thankyou for visiting
nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.
The editors of Nature Reviews Genetics will be posting about the latest developments in research and policy, and providing news about the journal. If you have any questions or feedback for us, get in touch by email or on Twitter.
Finding it hard to navigate the flood of scientific literature? The Nature Reviews journals filter and highlight the most impactful research. Take a look at this animation to learn how Nature Reviews Genetics can help you stay up-to-date, or visit
www.springernature.com/naturereviews
Advances in genomic technologies have enabled investigations into a wide range of species. In this Review, the authors describe recent studies in both non-model and model organisms that illustrate the diversity of animal sex chromosomes with respect to their evolutionary histories and mechanistic roles in sex-determination systems.
RNA-binding proteins regulate the lifecycle of RNA, and their dysregulation is associated with diseases such as cancer and neurodegeneration. Using methods based on ultraviolet crosslinking followed by immunoprecipitation (CLIP), we can now begin to decode the mechanisms of the interactions between RNA-binding proteins and RNA. This Review discusses recent insights from and future applications of these methodologies.
Single-cell, spatial and multi-omic profiling technologies generate large-scale data that reveal the output of genome-scale experiments across diverse cells, tissues and organisms. Cole Trapnell reviews the underlying core statistical challenges that need to be tackled to harness the power of these technologies and advance our understanding of gene function in health and disease.
In this Review, Pfeifer and Jin discuss currently available methods for genome-wide mapping of DNA damage and rare mutations and illustrate how these technologies are being used to study mechanisms of mutagenesis linked to the aetiology of human diseases.
In this Review, Pinto and Bhatt provide an overview of DNA-sequencing and RNA-sequencing approaches that can be used to study the composition, structure, and function of microbiomes and discuss the biological insights they provide.
In this Tools of the Trade article, Andrey Tvardovskiy and Saulius Lukauskas introduce the web resource MARCS, which offers a set of visualization tools to explore chromatin regulatory circuits from either a protein- or modification-centred perspective.
Identification of 34 common variant genes and three rare variant genes associated with VV, validated in FinnGen, including 17 novel genes, and found strong associations with body size, inflammation, and pulmonary function through phenome-wide association analyses.
Significant overlap among candidate genes identified in the three transects, which are diverse in function (metabolism, immunity, cardiac function, circadian rhythm), and show parallel shifts in allele frequency across latitudinal gradients.
PLOS ONE is now accepting submissions of Lab Protocols, a peer-reviewed article collaboration with
protocols.io, and Study Protocols, an article that credits the work done prior to producing and publishing results.
Congratulations to Associate Editor Harmit Malik, who was awarded the Edward Novitski Prize by the Genetics Society of America for his work on genetic conflict. Harmit has also been elected as a new member of the American Academy of Arts & Sciences.
GeneReviews, an international point-of-care resource for busy clinicians,provides clinically relevant and medically actionable information for inherited conditionsin a standardized journal-style format, covering diagnosis, management, and genetic counseling for patients and their families. Each chapter in GeneReviews iswritten by one or more experts on the specific condition or disease and goes through arigorous editing and peerreview process before being published online.
To ensure continuing relevant and medically actionable content, eachGeneReviews chapter is updated every four to five years (or as needed) by theauthor(s) in a formal and comprehensive process curated by the GeneReviewseditors. Additional revisions may occur morefrequently as needed to reflect significant changes in clinically relevant information.
Genetic counseling and testing terms used in GeneReviews are hyperlinkedto definitions in the GeneReviewsGlossary. Resource Materials include additional information on keygenetics concepts used in GeneReviews.
Reviewers are critical to our mission to see that NIH grant applications receive, fair, independent, expert, and timely scientific reviews. We appreciate the generosity with which reviewers give their time.
The Molecular Genetics and Genomics Review Branch is led by Dr. Elena Smirnova as Chief. The Review Branch will review research applications on fundamental and applied aspects of genes, genomes and genetics of humans and other organisms. Areas considered are fundamental mechanisms and regulation of gene expression, including chromosome function and maintenance, the regulation of DNA and RNA metabolism, translation, and posttranslational modification. Genomic studies, computational biology and technology development will also be considered, including development of new genetic tools and resources, global analysis of genetic systems, biological and computational resource development, and classification, storage, access, analysis and integration of genetic and other biological information. Genetic variation and evolution will be reviewed under the MGG Review Branch including the description, analysis and modeling of induced and natural genome variation, and comparisons between species. All aspects of quantitative genetics including complex trait mapping will be considered in humans and a wide variety of other species. The involvement of genetics in human health and disease will be considered, including the discovery, application and interpretation of gene and genomic variation influencing phenotype and the development of experimental and computational approaches to the identification of disease-related genes. Proposals dealing with model systems of all organisms, as they relate to human health and disease, will be considered, as will translational genetic studies applying fundamental genetic insight into the clinical setting.
Journal of Medical Genetics is a leading international peer-reviewed journal covering original research in human genetics, including reviews of and opinion on the latest developments. Articles cover the molecular basis of human disease including germline cancer genetics, clinical manifestations of genetic disorders, applications of molecular genetics to medical practice and the systematic evaluation of such applications worldwide.
The Cancer Genetics [CG] Study Section reviews applications related to the identification and characterization of target genes involved in tumor pathogenesis. Applications in the area of genomic instability and epigenetics are also reviewed in this study section. Translational studies using mammalian and non-mammalian models, and cell lines are included.
The Cancer Genetics [CG] Study Section reviews applications related to the identification and characterization of target genes involved in tumor pathogenesis using global scale genomic and epigenomic approaches. Applications in the research area of genomic instability are also reviewed in this study section.
The List of Reviewers lists all present, whether standing members or temporary, to provide the full scope of expertise present on that date. Lists are posted 30 days before the meeting and are tentative, pending any last minute changes.
There are shared interests with Gene Regulation in Cancer (GRIC) in the chromatin remodeling and epigenetics in tumorigenesis. Applications that focus on identified targets and pathways in tumorigenesis may be reviewed in GRIC. Applications that focus on chromatin remodeling and epigenetics on a global scale may be reviewed in CG.
There are shared interests in genetic predisposition to cancer with Cancer and Hematologic Disorders (CHD). Applications that emphasize cancer genetic and epigenetic studies in both animals and humans with the aim of identifying genes and gene regulation that modifies susceptibility to cancer and molecular pathways involved in cancer pathogenesis are reviewed in CG. Applications that emphasize genetic epidemiology of cancer in human subpopulations relating genetic and epigenetic risk factors and biomarkers with cancer incidence and disease progression are reviewed in CHD.
There are shared interests with Biochemical and Cellular Oncogenesis (BCO) in studies of genomic instability caused by DNA damage in carcinogenesis. Applications that study genomic instability with a focus on DNA damage and repair during tumor initiation will be assigned to BCO. Applications that focus on genetic and epigenetic aspects of genomic instability may be assigned to CG.
Peer reviewers are vital to science; yet, early career scientists in our field rarely receive formal training to be effective reviewers. Proper training allows them to develop skills central to their success including understanding the expectations of peer reviewers and editors, critical thinking, evaluating research, and providing constructive scientific feedback.
GSA is addressing this gap in training by providing early career members with real-world peer review experience through online training and advice from GENETICS and G3: GenesGenomesGenetics editors. Participants will become reviewers for manuscripts submitted to the GSA Journals. Early career scientists from anywhere in the world are encouraged to apply. We particularly welcome applications from members who lack opportunities to receive peer review training in their home labs or departments.
3a8082e126